NASDAQ:JYNT Joint Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Joint Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $16.64 -0.27 (-1.60 %) (As of 09/22/2020 12:00 AM ET) Add Compare Share Today's Range$16.31Now: $16.64▼$17.0650-Day Range$14.26MA: $17.42▼$18.5352-Week Range$7.67Now: $16.64▼$21.75Volume23,406 shsAverage Volume114,517 shsMarket Capitalization$233.14 millionP/E Ratio83.20Dividend YieldN/ABeta1.18 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingJoint has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $21.75, Joint has a forecasted upside of 30.7% from its current price of $16.64.Amount of Analyst CoverageJoint has only been the subject of 2 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesJoint has received 241 “outperform” votes. (Add your “outperform” vote.)Underperform VotesJoint has received 240 “underperform” votes. (Add your “underperform” vote.)Community SentimentJoint has received 50.10% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Joint and other stocks. Vote “Outperform” if you believe JYNT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe JYNT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldJoint does not currently pay a dividend.Dividend GrowthJoint does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Joint insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.70% of the stock of Joint is held by insiders.Percentage Held by Institutions77.28% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Joint are expected to grow by 78.95% in the coming year, from $0.19 to $0.34 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Joint is 83.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.41.Price to Earnings Ratio vs. SectorThe P/E ratio of Joint is 83.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.63.Price to Book Value per Share RatioJoint has a P/B Ratio of 40.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.78 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Patent owners & lessors Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:JYNT Previous Symbol CUSIPN/A CIK1612630 Webwww.thejoint.com Phone480-245-5960Debt Debt-to-Equity Ratio2.02 Current Ratio1.27 Quick Ratio1.27Price-To-Earnings Trailing P/E Ratio83.20 Forward P/E Ratio87.58 P/E GrowthN/A Sales & Book Value Annual Sales$48.45 million Price / Sales4.81 Cash Flow$0.35 per share Price / Cash Flow47.64 Book Value$0.41 per share Price / Book40.59Profitability EPS (Most Recent Fiscal Year)$0.23 Net Income$3.32 million Net Margins5.38% Return on Equity47.43% Return on Assets6.26%Miscellaneous Employees138 Outstanding Shares14,011,000Market Cap$233.14 million Next Earnings Date11/5/2020 (Estimated) OptionableNot Optionable $16.64 -0.27 (-1.60 %) (As of 09/22/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive JYNT News and Ratings via Email Sign-up to receive the latest news and ratings for JYNT and its competitors with MarketBeat's FREE daily newsletter. Joint (NASDAQ:JYNT) Frequently Asked Questions How has Joint's stock price been impacted by Coronavirus? Joint's stock was trading at $13.61 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, JYNT stock has increased by 22.3% and is now trading at $16.64. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Joint? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Joint. When is Joint's next earnings date? Joint is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. View our earnings forecast for Joint. How were Joint's earnings last quarter? Joint Corp (NASDAQ:JYNT) issued its earnings results on Thursday, August, 6th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.06) by $0.07. The business had revenue of $12.59 million for the quarter, compared to analysts' expectations of $10.13 million. Joint had a return on equity of 47.43% and a net margin of 5.38%. View Joint's earnings history. What price target have analysts set for JYNT? 4 brokerages have issued 12 month price objectives for Joint's stock. Their forecasts range from $20.00 to $24.00. On average, they anticipate Joint's stock price to reach $21.75 in the next year. This suggests a possible upside of 30.7% from the stock's current price. View analysts' price targets for Joint. Who are some of Joint's key competitors? Some companies that are related to Joint include Liberty Tax (TAXA), VirnetX (VHC), Acacia Research (ACTG), Quarterhill (QTRH), Quarterhill (QTRHF), Research Frontiers (REFR), Marathon Patent Group (MARA), Network-1 Technologies (NTIP), Finjan (FNJN), XCel Brands (XELB), Health Discovery (HDVY), Micro Imaging Technology (MMTC), MGT Capital Investments (MGTI), Spherix (SPEX) and ARC Group (ARCK). View all competitors. What other stocks do shareholders of Joint own? Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), Aurora Cannabis (ACB), Adobe (ADBE), Mastercard (MA), NVIDIA (NVDA), Raytheon Technologies (RTX), salesforce.com (CRM), Lululemon Athletica (LULU), Okta (OKTA) and Starbucks (SBUX). Who are Joint's key executives? Joint's management team includes the following people: Mr. Peter D. Holt, CEO, Pres & Director (Age 60)Jake Singleton, Chief Financial Officer (Age 37)Mr. Jorge Armenteros, VP of OperationsDr. James Edwards, Chief Chiropractic & Compliance OfficerMr. Craig P. Colmar, Sec. (Age 66) When did Joint IPO? (JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager. What is Joint's stock symbol? Joint trades on the NASDAQ under the ticker symbol "JYNT." Who are Joint's major shareholders? Joint's stock is owned by a variety of retail and institutional investors. Top institutional investors include Skylands Capital LLC (5.30%), Goldman Sachs Group Inc. (3.21%), Wasatch Advisors Inc. (3.10%), Cadence Capital Management LLC (0.93%), RK Capital Management LLC (0.91%) and WINTON GROUP Ltd (0.83%). Company insiders that own Joint stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Peter D Holt and Ronald V Davella. View institutional ownership trends for Joint. Which institutional investors are selling Joint stock? JYNT stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Nuveen Asset Management LLC, Trexquant Investment LP, AQR Capital Management LLC, Engineers Gate Manager LP, Bridgeway Capital Management Inc., and UBS Group AG. View insider buying and selling activity for Joint. Which institutional investors are buying Joint stock? JYNT stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., RK Capital Management LLC, O Brien Greene & Co. Inc, Two Sigma Advisers LP, WINTON GROUP Ltd, PDT Partners LLC, SG Americas Securities LLC, and Bank of America Corp DE. Company insiders that have bought Joint stock in the last two years include Bandera Partners Llc, Jake Singleton, James H Amos Jr, and Peter D Holt. View insider buying and selling activity for Joint. How do I buy shares of Joint? Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Joint's stock price today? One share of JYNT stock can currently be purchased for approximately $16.64. How big of a company is Joint? Joint has a market capitalization of $233.14 million and generates $48.45 million in revenue each year. The company earns $3.32 million in net income (profit) each year or $0.23 on an earnings per share basis. Joint employs 138 workers across the globe. What is Joint's official website? The official website for Joint is www.thejoint.com. How can I contact Joint? Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected] This page was last updated on 9/23/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
